Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 55

    Sun Pharma arm-SPARC updates on Paclitaxel Injection Concentrate for Suspension litigation

    Sun Pharma arm-SPARC updates on Paclitaxel Injection Concentrate for Suspension litigation

    Farhat Nasim9 Dec 2019 3:56 PM IST
    "Abraxis Biosciences LLC has dismissed the patent infringement complaint filed against Sun Pharma Advanced Research Co Ltd regarding SPARC's New Drug...
    Solara Active Pharma names Bharath R Sesha as new CEO

    Solara Active Pharma names Bharath R Sesha as new CEO

    Farhat Nasim9 Dec 2019 3:15 PM IST
    "The Board of Directors, on the recommendation of Nomination and Remuneration Committee, have appointed Bharath R Sesha as Chief Executive Officer of...
    Amgen biosimilar to JnJ arthritis drug Remicade gets USFDA approval

    Amgen biosimilar to JnJ arthritis drug Remicade gets USFDA approval

    Medical Dialogues Bureau9 Dec 2019 1:00 PM IST
    Amgen Inc's biosimilar, Avsola, has the same chemical components, dosage form and strength as Remicade and would treat a range of autoimmune...
    CDSCO directs Veterinary manufacturers to submit Periodic Safety Reports every 6 months for first 2 years

    CDSCO directs Veterinary manufacturers to submit Periodic Safety Reports every 6 months for first 2 years

    Farhat Nasim9 Dec 2019 12:12 PM IST
    The direction to submit PSURs came after various stakeholders of Veterinary products raised a concern regarding the clarification with respect to...
    GAVI to invest USD 178 million for creating Ebola vaccine stockpile

    GAVI to invest USD 178 million for creating Ebola vaccine stockpile

    Farhat Nasim9 Dec 2019 9:30 AM IST
    Since the latest outbreak in Congo was identified last August, health officials have immunised more than 255, 000 people with a recently licensed...
    Bristol-Myers, bluebird cancer therapy meets goal in mid-stage trial

    Bristol-Myers, bluebird cancer therapy meets goal in mid-stage trial

    Medical Dialogues Bureau9 Dec 2019 9:15 AM IST
    The study evaluated the efficacy and safety of the therapy, Ide-cel, in patients who had received three prior treatments for multiple myeloma, a...
    Bayer, plaintiffs to postpone more glyphosate lawsuits for settlement talks

    Bayer, plaintiffs to postpone more glyphosate lawsuits for settlement talks

    Medical Dialogues Bureau9 Dec 2019 9:00 AM IST
    Bayer acquired the weed killer brands last year as part of a $63 billion takeover of Monsanto, has ruled out pulling the products from the U.S....
    Govt action against BioMed contaminated polio vaccine supply; Minister informs RS

    Govt action against BioMed contaminated polio vaccine supply; Minister informs RS

    Farhat Nasim8 Dec 2019 11:30 AM IST
    New Delhi: The Minister in the Ministry of Health and Family Welfare, Ashwini Kumar Choubey recently informed the Parliament about the action taken by...
    Dabur eyes to acquire firms, expand in rural India with Rs 3500 crore war chest: Report

    Dabur eyes to acquire firms, expand in rural India with Rs 3500 crore war chest: Report

    Farhat Nasim8 Dec 2019 9:45 AM IST
    “We have a ready war chest available to acquire companies,” Malhotra said, adding that Dabur has reserves of up to 35 billion rupees ($490 million)....
    Generic versions of Novartis blockbuster MS drug Gilenya gets USFDA green flag

    Generic versions of Novartis blockbuster MS drug Gilenya gets USFDA green flag

    Medical Dialogues Bureau8 Dec 2019 9:38 AM IST
    The approval allows HEC Pharm Co Ltd, Biocon Ltd and Sun Pharmaceutical Industries Ltd to produce Gilenya for the treatment of relapsing forms of MS...
    AstraZeneca-Merck cancer drug Lynparza wins approval in China

    AstraZeneca-Merck cancer drug Lynparza wins approval in China

    Medical Dialogues Bureau8 Dec 2019 9:20 AM IST
    Lynparza is currently approved in 65 countries for the maintenance treatment of platinum-sensitive relapsed ovarian cancer, AstraZeneca and Merck...
    GSK seeks USFDA approval for investigational HIV treatment Fostemsavir

    GSK seeks USFDA approval for investigational HIV treatment Fostemsavir

    Medical Dialogues Bureau8 Dec 2019 9:15 AM IST
    GSK Plc's Fostemsavir is being developed for use in combination with other antiretroviral agents in adults who have been previously taken treatments...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok